Breaking
Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect ProgramEli Lilly's Legal Victory Over Noom's GLP-1 ClaimsBBSW AI Solution Event: Daily Roundup
Thursday, June 18, 2026
🇺🇸 FDA

Immunology Analysis

🇺🇸 FDA

Expert commentary and market intelligence for pharma strategy teams

Showing 1–2 of 2 articles

High impact AnalysisJun 7, 2026

AbbVie Cerevel acquisition closes in $8.7B neuroscience deal

immunology · 6 min

Dr. Sarah Mitchell
High impact AnalysisJun 7, 2026

AbbVie closes $8.7B Cerevel deal as neuroscience pipeline expands

U.S. Federal Trade Commission · immunology · 5 min

Dr. Sarah Mitchell

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.